SCHEMBL17611697

SCHEMBL17611697

C=C1CN(C(=O)O)CCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4772854 0.80 NOTUM (0.31)
SCHEMBL139222 0.76
SCHEMBL60542 0.73
SCHEMBL17868263 0.72
Ammonia Solution, Strong SCHEMBL27931519 0.71 HSP90AA1 (0.42)
SCHEMBL114393 0.70 HSP90AA1 (0.42)
SCHEMBL14096752 0.68
SCHEMBL894830 0.68 DPP8 (0.34)
Formamide SCHEMBL27905692 0.68 DPP8 (0.40)
SCHEMBL362028 0.67 PKM (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3194397-A1 2-[BIS(4-FLUOROPHENYL)METHYL]-2,7-DIAZASPIRO[4.5]DECAN-10-ONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE HUMAN DOPAMINE-ACTIVE-TRANSPORTER (DAT) PROTEIN FOR THE TREATMENT OF E.G. ATTENTION DEFICIT DISORDER (ADD) Chronos Therapeutics Limited (GB) 2017-07-26 EP disclosed
WO-2016042451-A1 2-[BIS(4-FLUOROPHENYL)METHYL]-2,7-DIAZASPIRO[4.5]DECAN-10-ONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE HUMAN DOPAMINE-ACTIVE-TRANSPORTER (DAT) PROTEIN FOR THE TREATMENT OF E.G. ATTENTION DEFICIT DISORDER (ADD) SHIRE INTERNATIONAL GMBH (CH) 2016-03-24 WO disclosed